Cognitive Profile in Parkinson’s Disease Dementia Patients with Low versus Normal Cerebrospinal Fluid Amyloid Beta

Introduction: In patients with Parkinson’s disease (PD), low cerebrospinal fluid (CSF) amyloid beta 1-42 (Ab42) at baseline is the most consistent CSF biomarker as a risk factor for developing dementia. Low CSF Ab42 is, however, a typical hallmark of Alzheimer’s disease (AD). Hence, low CSF Ab42 in...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Zeynep Tufekcioglu, Johannes Lange, Kenn Freddy Pedersen, Ole-Bjørn Tysnes, Guido Alves, Murat Emre
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Karger Publishers 2023-10-01
Sarja:	Dementia and Geriatric Cognitive Disorders Extra
Aiheet:	parkinson’s disease dementia cerebrospinal fluid amyloid beta cognitive assessment
Linkit:	https://beta.karger.com/Article/FullText/534552
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!